Pages that link to "Q36396476"
The following pages link to What do effective treatments for multiple sclerosis tell us about the molecular mechanisms involved in pathogenesis? (Q36396476):
Displaying 15 items.
- Distinguishing Susac's syndrome from multiple sclerosis (Q30882185) (← links)
- Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis (Q33755345) (← links)
- Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis. (Q38107524) (← links)
- Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis (Q38114422) (← links)
- Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis (Q38192006) (← links)
- Tecfidera(®): an approach for repurposing. (Q38192708) (← links)
- Alterations in serum levels of IL-17 in contrast to TNF-alpha correspond to disease-modifying treatment in relapsing-remitting multiple sclerosis (Q38893637) (← links)
- Probabilistic Modeling of Imaging, Genetics and Diagnosis (Q39990261) (← links)
- Modern analytics for synthetically derived complex drug substances: NMR, AFFF-MALS, and MS tests for glatiramer acetate (Q40441110) (← links)
- Multiple sclerosis: from molecules to treatment (Q43138599) (← links)
- PGE2 contributes to in vitro MSC-mediated inhibition of non-specific and antigen-specific T cell proliferation in MS patients (Q47780740) (← links)
- Circulating levels of interleukin-17A, tumor necrosis factor-alpha, interleukin-18, interleukin-10, and cognitive performance of patients with relapsing-remitting multiple sclerosis. (Q49349492) (← links)
- Does Natalizumab Induce or Aggravate Psoriasis? A Case Study and Review of the Literature (Q57493087) (← links)
- Advances in the treatment of relapsing-remitting multiple sclerosis: the role of pegylated interferon β-1a. (Q64988430) (← links)
- The effects of transplanted mesenchymal stem cells treated with 17-b estradiol on experimental autoimmune encephalomyelitis (Q90296110) (← links)